Wuhan Huakang Century Medical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000057D4
CNY
48.95
-0.36 (-0.73%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
596.57
539.64
292.25
628.22
525.70
324.21
229.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
596.57
539.64
292.25
628.22
525.70
324.21
229.71
Raw Material Cost
390.35
351.70
236.41
423.91
363.61
197.03
169.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.81
8.80
8.78
6.76
5.63
5.23
4.41
Selling and Distribution Expenses
132.34
106.03
56.97
118.85
102.84
97.07
72.47
Other Expenses
1.28
0.02
1.00
0.71
0.87
0.57
0.99
Total Expenditure (Excl Depreciation)
544.34
466.77
312.17
556.65
480.75
305.00
256.80
Operating Profit (PBDIT) excl Other Income
52.199999999999996
72.9
-19.9
71.6
44.900000000000006
19.2
-27.1
Other Income
1.49
-2.28
1.52
3.02
0.22
5.64
1.35
Operating Profit (PBDIT)
51.98
73.20
-10.11
78.18
56.55
32.33
-20.79
Interest
8.81
8.80
8.78
6.76
5.63
5.23
4.41
Exceptional Items
0.00
-0.05
0.00
0.05
0.00
0.00
0.00
Gross Profit (PBDT)
206.22
187.94
55.84
204.31
162.09
127.18
59.72
Depreciation
0.00
8.32
8.32
14.47
14.47
8.38
8.38
Profit Before Tax
43.17
56.04
-27.21
56.99
36.45
18.72
-33.59
Tax
0.23
8.00
0.83
9.86
6.16
-2.59
-1.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.47
47.64
-28.95
47.17
30.40
21.30
-32.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.47
47.64
-28.95
47.17
30.40
21.30
-32.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.46
0.40
0.92
-0.05
-0.11
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.94
48.04
-28.04
47.13
30.29
21.30
-32.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,837.36
1,747.13
1,757.65
1,798.63
1,777.30
1,742.12
1,726.62
Earnings per share (EPS)
0.41
0.46
-0.28
0.45
0.29
0.2
-0.3
Diluted Earnings per share
0.41
0.46
-0.28
0.45
0.29
0.2
-0.3
Operating Profit Margin (Excl OI)
8.46%
12.45%
-6.82%
9.66%
7.96%
5.65%
-13.29%
Gross Profit Margin
7.24%
11.93%
-6.46%
11.38%
9.69%
8.36%
-10.97%
PAT Margin
7.12%
8.83%
-9.91%
7.51%
5.78%
6.57%
-13.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 13.49% vs 16.28% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 41.58% vs -17.44% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -10.30% vs 11.71% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 57.14% vs 60.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Wuhan Huakang Century Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
596.57
0
596.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
596.57
0
596.57
Raw Material Cost
390.35
0
390.35
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.81
0
8.81
Selling and Distribution Expenses
132.34
0
132.34
Other Expenses
1.28
0.00
1.28
Total Expenditure (Excl Depreciation)
544.34
0
544.34
Operating Profit (PBDIT) excl Other Income
52.23
0.00
52.23
Other Income
1.49
0
1.49
Operating Profit (PBDIT)
51.98
0
51.98
Interest
8.81
0
8.81
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
206.22
0
206.22
Depreciation
0.00
0
0.00
Profit Before Tax
43.17
0
43.17
Tax
0.23
0
0.23
Provisions and contingencies
0
0
0.00
Profit After Tax
42.47
0
42.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.47
0
42.47
Share in Profit of Associates
0
0
0.00
Minority Interest
0.46
0
0.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.94
0
42.94
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,837.36
0
1,837.36
Earnings per share (EPS)
0.41
0
0.41
Diluted Earnings per share
0.41
0
0.41
Operating Profit Margin (Excl OI)
8.46%
0%
0.00
8.46%
Gross Profit Margin
7.24%
0%
0.00
7.24%
PAT Margin
7.12%
0%
0.00
7.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 59.66 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 10.56% vs 84.60% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 13.49% vs 16.28% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.29 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -10.62% vs 271.43% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 41.58% vs -17.44% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.05 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -33.11% vs 750.86% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.30% vs 11.71% in Sep 2024

Quarterly - Interest
Interest 0.88 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 57.14% vs 60.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.46%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024